secwatch.observer — SEC 8-K summary
======================================

Issuer:     SpyGlass Pharma, Inc. (SGP)
CIK:        0001778922
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001628280-26-008073
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

SpyGlass Pharma discloses FY2025 performance cash bonuses for named executive officers
--------------------------------------------------------------------------------

- Compensation Committee approved FY2025 bonuses on Feb 12, 2026.
- CEO Patrick Mooney: $215,088 bonus; total compensation $3,322,711.
- President/CMO Malik Y. Kahook: $125,975 bonus; total $2,484,469.
- Chief R&D Officer Chetan Pujara: $126,289 bonus; total $1,539,952.
- Bonuses previously undisclosed in S-1; updated comp table filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1778922/000162828026008073/0001628280-26-008073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1778922/000162828026008073/spyglass-form8xk502fx2025c.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-008073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer